200 filings
Page 10 of 10
6-K
s2ffi
3 Jun 20
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
10:41am
6-K
xec46
27 May 20
Current report (foreign)
3:45pm
6-K
2h17gg
15 May 20
Management’s Discussion and Analysis of Financial Condition and Results of
10:48am
6-K
02h721y9
23 Mar 20
FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario
4:12pm
6-K
let6rwud tb1e04y5
18 Mar 20
Current report (foreign)
4:11pm
40-F/A
3dyja6g
17 Mar 20
Annual report (Canada) (amended)
5:14pm
6-K
6rqa9bhwgk il5oyjgw
9 Mar 20
Current report (foreign)
2:36pm
6-K
bnmhshvr86p75rxw
4 Mar 20
Current report (foreign)
4:37pm
40-F
5u1wlcleryjta6
4 Mar 20
Annual report (Canada)
12:29pm
F-X
fs93 62ce6cloh
28 Feb 20
Appointment of agent for service of process by issuers registering securities
5:00pm
F-10
78qzfq0vzh44wyuc
28 Feb 20
Registration of securities (Canada)
4:51pm
6-K
r58qr1
21 Feb 20
Current report (foreign)
6:02am
6-K
gxpt8zoocu09z5t6l
5 Feb 20
FSD Pharma and Solarvest Enhance Commitment to CBD Research Project
5:15pm
6-K
h406ojkajja
23 Jan 20
Seasoned Healthcare Executive and Academic Luminary Larry Kaiser, MD, Joins FSD Pharma Board of Directors
9:46am
6-K
ql3t2 wzt7qem
9 Jan 20
Current report (foreign)
5:02pm
CERT
jacvqn70 8dkk
8 Jan 20
Certification of approval for exchange listing
10:32am
F-X
8v91iv14
6 Dec 19
Appointment of agent for service of process by issuers registering securities
12:46pm
40FR12B
rd09odid8hicymhkdpb
6 Dec 19
Initial registration of securities (Canada)
12:28pm
D
5z2kev owgfmdpi
20 Nov 19
$10.04K in equity, sold $10.04K, 1 investor
12:00am
D
rwel0f2q8qshgqgan1b
15 Oct 19
$2.63M in equity, sold $2.63M, 12 investors
3:08pm